Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Disc Medicine (IRON)
NASDAQ:IRON
Disc Medicine (IRON) Stock Price & Analysis
199 Followers
IRON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.60 - $77.60
Previous Close$29
Volume271.44K
Average Volume (3M)479.06K
Market Cap
$704.15M
Enterprise Value$358.64M
Total Cash (Recent Filing)$360.38M
Total Debt (Recent Filing)$2.10M
Price to Earnings (P/E)-8.3
Beta0.60
Next Earnings
May 13, 2024EPS Estimate
-$1.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.50
Shares Outstanding24,681,028
10 Day Avg. Volume402,081
30 Day Avg. Volume479,064
Standard Deviation0.22
R-Squared0.00836
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.04
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.56
Forecast
1Y Price Target
$53.63Price Target Upside80.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Disc Medicine News
PremiumCompany Announcements
Disc Medicine’s Bitopertin Shows Promise in EPP Study
Bulls Say, Bears Say
Bulls Say
Drug EfficacyBitopertin treatment led to dose-dependent reductions in the rate of phototoxic reactions with pain and improvements in Patient Global Impression of Change.
Market PotentialBased on discussions with Key Opinion Leaders, there is confidence that bitopertin could become the standard treatment for EPP, capturing significant market share.
Regulatory MilestoneFDA's openness to new scientific and regulatory ideas during the EPP workshop suggests potential flexibility in endpoint selection for EPP treatments.
Bears Say
Clinical Trial OutcomesPatients treated with bitopertin's increase in cumulative total time in sunlight was not statistically significant compared to placebo.
Drug Efficacy ConcernsIf Bitopertin shows less than expected efficacy, with PPIX reduction and light tolerance improvement at lower thresholds, IRON's shares could trade down.
Financial PerformanceThe company reported a higher than expected loss per share and an increase in operating loss due to the advancement of its portfolio and increased headcount.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IRON FAQ
What was Disc Medicine’s price range in the past 12 months?
Disc Medicine lowest stock price was $25.60 and its highest was $77.60 in the past 12 months.
What is Disc Medicine’s market cap?
Currently, no data Available
When is Disc Medicine’s upcoming earnings report date?
Disc Medicine’s upcoming earnings report date is May 13, 2024 which is in 5 days.
How were Disc Medicine’s earnings last quarter?
Disc Medicine released its earnings results on Mar 21, 2024. The company reported -$0.9 earnings per share for the quarter, missing the consensus estimate of -$0.771 by -$0.129.
Is Disc Medicine overvalued?
According to Wall Street analysts Disc Medicine’s price is currently Undervalued.
Does Disc Medicine pay dividends?
Disc Medicine does not currently pay dividends.
What is Disc Medicine’s EPS estimate?
Disc Medicine’s EPS estimate is -$1.01.
How many shares outstanding does Disc Medicine have?
Disc Medicine has 24,721,464 shares outstanding.
What happened to Disc Medicine’s price movement after its last earnings report?
Disc Medicine reported an EPS of -$0.9 in its last earnings report, missing expectations of -$0.771. Following the earnings report the stock price went down -7.515%.
Which hedge fund is a major shareholder of Disc Medicine?
Among the largest hedge funds holding Disc Medicine’s share is Perceptive Advisors LLC. It holds Disc Medicine’s shares valued at 59M.
---
Disc Medicine Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$53.63 (80.03% Upside)
$53.63 (80.03% Upside)
Blogger Sentiment
Bullish
IRON Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 161.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 13.9%
Last 30 Days ▼ 13.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.04%
12-Months-Change
Fundamentals
Return on Equity
-29.30%
Trailing 12-Months
Asset Growth
83.81%
Trailing 12-Months
Company Description
Disc Medicine
FS Development Corp is a blank check company.
---
IRON Stock 12 Months Forecast
Average Price Target
$53.63
▲(80.03% Upside)
Technical Analysis
Best Analysts Covering IRON
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-30.64%
reiterated a buy rating last month
Copying Benjamin Burnett's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -30.64% per trade.
---